Connect with us
Nigerian Govt

Nigerian Govt Bans Tertiary Hospital From Using Foreign Syringes, Needles

More Videos

Published

on

Nigerian Govt Bans Tertiary Hospital From Using Foreign Syringes, Needles—-The Federal Government of Nigeria has mandated all Chief Medical Directors (CMDs) and Medical Directors (MDs) of Federal Tertiary Hospitals to procure needles and syringes solely from NAFDAC-approved local manufacturers.

The new directive is contained in a circular addressed to all CMDs and MDs signed by the Minister of State for Health, Dr Tunji Alausa, on Friday.

The minister said that the directive was aimed at boosting domestic production and shielding the country’s manufacturing sector from the influx of foreign goods.

The circular also mandated NAFDAC to stop issuing licences for the importation of foreign manufactured needles and syringes.

Alausa said the health sector had dentified local pharmaceutical industries that produce needles and syringes that were in serious trouble because of the practice.

He also said that out of the nine local pharmaceutical companies that produced needles and syringes eight years ago, six have folded up due to the dumping of largely substandard goods into the market.

“Mr President has directed that this must stop. We all agreed to take the necessary steps to immediately remedy this sad situation.

“Pursuant to this, NAFDAC has been mandated to stop issuing licences for the importation of foreign manufactured needles and syringes.

“It is also to de-list companies involved in the importation of these products going forward,” he said.

Alausa said ”all our tertiary hospitals are hereby directed to procure needles and syringes for your hospital needs from only the NAFDAC-approved local manufacturers listed below are listed either directly or through any of their vendors.

“EL-Salmat Pharmaceuticals Company Ltd Block, Brand Name: Salmaject, HMA Medical Ltd., with brand Name: Deleject and Afrimedical Manufacturing and Supplies Ltd.”

He also listed some of the distributors of the listed companies in some states of the Federation for easy access to assist in making the procurement process easier in the various institutions.

Facebook 0 Twitter/X 0 LinkedIn0 WhatsApp0 0Shares
Continue Reading
Click to comment

Leave a ReplyCancel reply

News

EL-Lab Medical Diagnostics And Research Centre Secures ReAccreditation To ISO 15189:2022

Published

on

EL-Lab Medical Diagnostics And Research Centre Secures ReAccreditation To ISO 15189:2022

 

EL-Lab, a leading Medical diagnostic centre in Lagos earns renewed Accreditation from the Nigeria National Accreditation System (NiNAS), affirming its continued technical competence in medical laboratory testing.

 

A medical diagnostic centre with branches across Lagos, EL-Lab is the First Indigenous medical laboratory in Nigeria to attain the ISO 15189 status in Nigeria ten years ago. Till date, Nigeria may have less than 50 medical laboratories in both public and private categories to meet this standard.

 

EL-LAB has maintained this accreditation status for ten (10) years and currently holds this qualification from two (2) accreditation bodies in Nigeria, namely Medical Laboratory Council of Nigeria (MLSCN) and Nigeria National Accreditation System (NiNAS)

 

This achievement of reaccreditation and transition to ISO 15189:2022 for Medical testing, following a rigorous reassessment by Nigeria National Accreditation System (NiNAS) confirms that EL-Lab continues to meet the requirements of ISO 15189:2022, the internationally recognised standard governing quality and competence in medical laboratories. It sets out requirements covering everything from sample handling and testing procedures to staff competence and quality management, giving patients, clinicians, and partner institutions confidence in the accuracy and reliability of results.

 

For a medical diagnostic laboratory, reaccreditation is no small feat. It requires laboratories to demonstrate, through an independent and thorough assessment, that its systems, processes, and personnel consistently deliver results in line with international best practice. NiNAS, as Nigeria’s national accreditation body, conducts these assessments to ensure that accredited laboratories maintain the standards necessary for both local and global recognition.

 

By retaining this accreditation, EL Lab reinforces its position as a trusted provider of medical testing services within Lagos and the broader Nigerian healthcare system.

 

Speaking on this, the Managing Director of EL-Lab, Dr Elochukwu Adibo mni said; “This achievement reflects the laboratory’s commitment to quality assurance, staff training, and process improvement, factors that lead to more reliable outcomes for patients and referring clinicians”.

 

For more information about EL-Lab Medical Diagnostics, visit their website:  https://el-lab.org/

 

 

Facebook 0 Twitter/X 0 LinkedIn0 WhatsApp0 0Shares
Continue Reading

News

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India

Published

on

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India—-Sri Lanka has stepped up monitoring measures following reports of a Nipah virus cluster in India’s eastern state of West Bengal.

Health authorities across parts of Asia have also heightened vigilance over the emerging situation, the Daily Mirror reported.

Health officials said Sri Lanka is tracking developments at the regional level and remains in contact with international health monitoring systems.

While no cases have been reported locally, authorities have indicated that preparedness measures are in place should the situation evolve.

The alert follows confirmation by Indian authorities of at least five Nipah virus infections in West Bengal, including cases among healthcare workers.

The development has prompted several countries in the region to strengthen preventive measures, particularly at international airports.

Nipah virus is a zoonotic disease transmitted between animals and humans and, in some instances, through human-to-human contact.

It is classified as a priority pathogen by the World Health Organisation due to its epidemic potential and the severity of illness it can cause. Past outbreaks of the Nipah virus have been associated with high fatality rates, ranging from 40 per cent to 75 per cent. (Xinhua/NAN)

Facebook 0 Twitter/X 0 LinkedIn0 WhatsApp0 0Shares
Continue Reading

Trending

Facebook 0 Twitter/X 0 LinkedIn0 WhatsApp0 0Shares